Biology subjects

Shungu, D. C.

Publications and source records attributed to Shungu, D. C..

2 recordsLinked to original sources

bioRxiv2025

Test-retest reliability of multi-metabolite edited MRS at 3T using PRESS and sLASER

PurposeSpectral editing is the most common MRS approach for noninvasive in vivo measurement of low-concentration, strongly overlapped metabolites in the brain, such as {gamma}-aminobutyric acid (GABA) and glutathione (GSH). Multi-metabolite editing methods, including HERMES and HERCULES, have recently been introduced, where multiple J-coupled metabolites can be edited in a single acquisition without increasing total scan time. Yet little is known regarding the reliability of these methods. This study assessed the test-retest reliability of HERMES and HERCULES, where volume localization was achieved using either PRESS or sLASER. MethodsSixteen healthy adult volunteers were scanned twice in two separate sessions. Single-voxel edited MRS data were acquired in the medial parietal lobe using the following sequences: (1) HERMES-PRESS; (2) HERMES-sLASER; (3) HERCULES-PRESS; (4) HERCULES-sLASER. Spectra were processed and metabolites were quantified using the Osprey software. Data quality metrics and reliability statistics were estimated for all four acquisitions. ResultsHERMES-sLASER demonstrated lower within-subjects coefficients of variation (CVws) for GSH, glutamine (Gln), and glutamate (Glu) + Gln (Glx), suggesting improved reliability compared to HERMES-PRESS. However, GABA + co-edited macromolecules (GABA+) and Glu showed higher CVws for HERMES-sLASER. HERCULES-sLASER produced better reliability than HERCULES-PRESS for GABA+, GSH, Glu, Gln, Glx, aspartate (Asp), and lactate (Lac). N-acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) showed higher CVws for HERCULES-sLASER. These findings suggest that sLASER may be more advantageous than PRESS for volume localization in simultaneous multi-metabolite editing. ConclusionUsing sLASER yielded better test-retest reliability for most metabolites than using PRESS for volume localization for HERMES and HERCULES.

neuroscience↗

bioRxiv2022

Single-cell transcriptomics of the immune system in ME/CFS at baseline and following symptom provocation

ME/CFS is a serious and poorly understood disease. To understand immune dysregulation in ME/CFS, we used single-cell RNA-seq (scRNA-seq) to examine immune cells in cohorts of patients and controls. Post-exertional malaise (PEM), an exacerbation of symptoms following strenuous exercise, is a characteristic symptom of ME/CFS. Thus, to detect changes coincident with PEM, we also performed scRNA-seq on the same cohorts following exercise. At baseline, ME/CFS patients displayed dysregulation of classical monocytes suggestive of inappropriate differentiation and migration to tissue. We were able to identify both diseased and more normal monocytes within patients, and the fraction of diseased cells correlated with metrics of disease severity. Comparing the transcriptome at baseline and post-exercise challenge, we discovered patterns indicative of improper platelet activation in patients, with minimal changes elsewhere in the immune system. Taken together, these data identify immunological defects present at baseline in patients and an additional layer of dysregulation following exercise. HighlightsME/CFS is a debilitating disease with unknown causes. Here, we provide, for the first time, an extensive single cell resolution dataset detailing the gene expression programs of circulating immune cells of ME/CFS cases at baseline and after symptom provocation. We were able to detect robust dysregulation in certain immune cells from patients, with dysregulation of classical monocytes manifesting the strongest signal. Indeed, the fraction of aberrant monocytes in ME/CFS patients correlated with the degree of disease severity. Surprisingly, platelet transcriptomes were also altered in ME/CFS, and they were the only component of the immune system that showed large-scale changes following symptom provocation.

immunology↗